Mental retardation and early Alzheimer's disease (AD) have generally been attributed to progressive neuronal loss in the developing and mature Down syndrome (DS) brain. However, reduced neuronal production during development could also contribute to the smaller brain size and simplified gyral patterning seen in this disorder. Here, we show impairments in proliferation within the ventricular zone (VZ) of early DS fetal cortex and in cultured early passage DS human neural progenitors (HNPs). We find that the reduced proliferative rates correspond temporally with increased expression of the chromosome 21 (HSA21) associated, oligodendrocyte transcription factor OLIG2 at 14 -18 weeks gestational age (GA) (period of neurogenesis). Moreover, the DS HNPs adopt more oligodendrocyte-specific features including increased oligodendrocyte marker expression, as well as a reduction in KCNA3 potassium channel expression and function. We further show that OLIG2 inhibition or over-expression regulates potassium channel expression levels and that activation or inhibition of these channels influences the rate of progenitor proliferation. Finally, neural progenitors from Olig2 over-expressing transgenic mice exhibit these same impairments in proliferation and potassium channel expression. These findings suggest that OLIG2 over-expression inhibits neural progenitor proliferation through changes in potassium channel activity, thereby contributing to the reduced neuronal numbers and brain size in DS.
INTRODUCTION
Down syndrome (DS) arises from triplication of chromosome 21 (HSA21). Over-expression of a subset of HSA21 genes results in mental retardation, epilepsy and Alzheimer's disease (AD). At the histological level, decreased neuronal numbers and reduced cortical volume have been reported in human DS brains and were largely attributed to neuronal degeneration and cell loss (1, 2) . These observations suggest that genetic mechanisms involving constitutive overexpression of HSA21 genes, leading to neuronal loss, might contribute to the DS clinical phenotype.
Both impaired generation of human neural progenitors (HNPs), through altered proliferation and/or increased HNPs cell death, could result in a decline in neuronal numbers.
Our prior studies implicated HSA21-associated genes S100B and APP in promoting oxidative stress, apoptosis and neuronal loss in HNPs (3, 4) . On the other hand, recent studies have reported impairments in proliferation within both the hippocampus and neocortical germinal matrix of 17-21-week (W) gestational age (GA) fetal DS brains (2, 5) . The cell cycle is prolonged with more DS cells remaining in G2 phase, thereby causing a reduction in neurogenesis and increase in astrocytosis later in development. Similar observations have been seen in trisomy 16 mouse models, showing a reduction in the progenitor pool and neurogenesis along the ventricular zone (VZ) or the subventricular zone (SVZ) of the dentate gyrus in embryonic and neonatal mice (5 -7) .
The molecular mechanisms giving rise to this altered proliferation are not entirely clear, although several genes on * To whom correspondence should be addressed. Tel: +1 6176674078; Fax: +1 6176677919; Email: vsheen@bidmc.harvard.edu # The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com HSA21, such as APP, S100B and DYRK1A, have been suggested to contribute to the phenotype (8 -11) . DYRK1A was shown to phosphorylate p53, induce p21 CIP1 upregulation and impair G1/G0-S phase transition, resulting in attenuated proliferation in human neural precursor cells (12) . In another report, DYRK1A over-expression was shown to induce p27 KIP1 and suppress NOTCH signaling, promoting cell cycle exit (8) . Dyrk1A overexpression also caused nuclear export and degradation of cyclin D1, inhibited proliferation, induced premature neuronal differentiation, but did not affect differentiation and migration in mouse neural progenitor cells (11) . The study of APP overexpression in the trisomy 16 model showed increased production of the APP intracellular domain, which increased ptch1 and downregulated the sonic hedgehog homolog pathway, resulting in reduced proliferation of neural progenitor cells in hippocampus and SVZ (13) . Another report showed that APP phosphorylation at threonine-668 was required for APP and APP-BP1 binding. APP-BP1 degradation induced G1 arrest and decreased proliferation in rat neural stem cells (9) . Finally, the HSA21-localized S100B contributes to p53-induced G1 arrest (10) . These findings collectively raised the possibility of interactions between various HSA21 genes in the regulation of progenitor proliferation.
Our prior studies suggested a glia progenitor shift in DS HNPs when compared with age-matched controls, raising the possibility that changes in proliferative rates might be due to phenotypic differences between age-matched normal and DS progenitors (3, 4) . The inflammatory and pro-gliogenic factors in DS push progenitors toward a more mature glial progenitor phenotype, rather than maintaining a more immature neural progenitor phenotype. In this setting, the glial progenitors would show a reduction in proliferative rates (i.e. more mature cells tend to replicate more slowly than immature cells). While we showed that the glia progenitor shift was partially due to reactive inflammation from APP and S100B-dependent cell death, the constitutive over-expression of HSA21-localized OLIG1/2 transcription factors might further contribute to both proliferative and cell fate changes in DS HNPs, given that they have previously been implicated in these developmental processes (14) (15) (16) . Moreover, OLIG2+ progenitor numbers increase with injury and they preferentially differentiate into glial fibrillary acidic protein+ reactive astrocytes (17) . Here, we report impaired proliferation in DS HNPs along the VZ of frontal cortex at 14 -18 W GA. Whole-cell electrophysiological recordings showed decreased voltage-gated outward potassium currents in DS HNPs, consistent with an oligoprogenitor phenotype. OLIG2 but not OLIG1 was preferentially over-expressed in DS progenitors and paralleled increasing expression of other oligodendroglial-associated markers and decline in neuronal markers. We find that OLIG2 expression levels regulate KCNA3 potassium channel expression, and that potassium channel activity can dictate HNPs proliferative rates. In this respect, the neuronal loss seen in early DS development not only results from DS HNPs injury and apoptotic cell death due to HSA21located S100B and APP, but also alterations in K+ channel activity and expression due to HSA21-located Olig2. Overexpression of these HSA21 genes fundamentally redirects progenitor phenotypes and thereby alters the expansion and composition of the developing cortex.
RESULTS

Impaired proliferation in DS HNPs
While reduced neural progenitor proliferation has been broadly reported in the VZ and SVZ of the dentate gyrus in embryos and neonates of DS animal models (5 -7) , few studies have addressed the issue in human DS fetal brain (2, 5) . Our prior expression profiling studies and network analyses suggest that dysregulated genes in DS HNPs form functional clusters involved in cell cycle and proliferation, and would predict some disruption in neural progenitor proliferation (3) . To formally test these initial observations, we asked whether these endophenotypes could be identified in both tissue and HNPs from 14 to 18 W GA DS frontal cortex. There was a 3-to 4-fold decrease in proliferation as assessed by the cell cycle marker Ki67 and the M-phase marker phospho-histone H3 (PH3) immunostaining along the VZ and SVZ in multiple 18 W GA DS frontal cortices ( Fig. 1A ). This same decline in proliferation in the DS cortex was consistent with the quantitative decrease in the proliferating cell nuclear antigen (PCNA), a protein in the nuclei of cells that is expressed during the DNA synthesis phase of the cell cycle, as shown by western blot analyses and immunoblotting ( Fig. 1B) . A corresponding decline in proliferation could be appreciated in vitro with neurospheres, generated and expanded from multiple 18 W GA DS frontal cortices. The DS HNPs showed an approximate 3-fold decrease in levels of Ki67 or BrdU labeling and a 40% reduction in neurosphere size, following expansion from individual progenitors at 1 W (Fig. 1C ). Lastly, the 18 W GA DS and control (CON) progenitors were plated at low density and allowed to expand for 1 W (Fig. 1D ). Again, a significant reduction in the number of cells that composed a single clonal cluster was observed in the DS HNPs (generally 1 -5 cells per cluster) when compared with CON HNPs (generally 5-10 cells per cluster). Overall, these findings are consistent with decreased neural progenitor proliferation during DS cortical development.
Shift in the DS HNP progenitor pool toward oligodendroglial phenotypes
Our prior studies have shown that APP and S100B synergistically increase cell death and gliosis in DS, in part causing a shift in the progenitor pool toward astroglial cell fates (4) . The number of OLIG2(+) progenitors also increases in the injured CNS, and OLIG2(+) cells preferentially differentiate into GFAP-expressing astrocytes, the main contributors to glial scars which further secrete S100B, leading to further astrocytosis and cell injury (17) . Changes in HNPs cell fate phenotypes due to over-expression of HSA21 genes therefore might contribute to differences in proliferation. We began evaluating the temporal expression levels of neuronal and glial markers in DS compared with CON progenitors from 14 W ( Fig. 2A ) and 18 W ( Fig. 2B ) GA frontal cortices. The oligodendroglial progenitor marker OLIG2 was significantly upregulated in DS samples of both ages, and expression levels paralleled those seen with upregulation of another oligodendrocyte precursor marker PDGFRA. On the other hand, OLIG1 was increased in the 18 W but not 14 W DS Human Molecular Genetics, 2012, Vol. 21, No. 10 2331
samples. This observation is consistent with the previous report of OLIG1 and OLIG2 expression in as early as 15 W GA human frontal cortex (18) . As shown previously, the astroglial marker GFAP was also increased in both DS ages. Conversely, the neuronal progenitor marker PAX6 showed reduced expression in both ages, whereas the neuronal marker MAP2 was reduced in both DS ages, albeit more significantly in 18 W. The increased expression of oligoprogenitor markers (OLIG2, PDGFRA) and oligodendrocyte marker (MBP), and the decreased expression of immature neuronal marker (DCX) and neuronal marker (MAP2) were also observed by immunostaining in the VZ of DS 18 W GA frontal cortices (Supplementary Material, Fig. S2 ).
These findings would suggest that DS HNPs may fundamentally adopt more oligodendroglial phenotypes over time, possibly in relationship to OLIG2 and less so to OLIG1 over-expression, given that the latter protein is not appreciably increased until later in development.
Decreased voltage-dependent K1 currents and expression in DS HNPs
There is increasing evidence that K+ channels influence cell growth and differentiation of progenitors (19) (20) (21) (22) . To test the functional changes of HNPs in DS, we obtained electrophysiological recordings of HNPs from 18 W GA CON and DS frontal cortices by comparison and pooling of electrophysiological data from multiple samples. HNPs were round in morphology and appeared undifferentiated. Additionally, these cells were not hyperexcitable ( Fig. 3A , upper panel). Table 1 summarizes the number of cells, conditions and protocols used in the present studies. Two different voltage protocols were used with activation at 0 and 2120 mV, in the presence (KAsp) or the absence of internal K+. Voltage stimulation conducted by holding the resting potential at 2120 mV showed increased whole-cell currents in both cell groups. On average, CON cells showed higher whole-cell currents than DS cells ( Fig. 3A , middle panel). This was only evident after voltage stimulation from 2120 mV, but not when cells were held at 0 mV ( Fig. 3A , middle panel). Nonetheless, there was a clear difference in the reversal potential of the whole-cell currents in the DS cells under either voltage protocol ( Table 2 ). In the absence of intracellular K+ and under conditions to block K+ channels, the outward rectifying currents were no longer present ( Fig. 3A, lower panel) . These data showed differences in stable, non-transient (voltage-inactivated) currents. Subtraction of the stable currents at 380 ms from each tracing unmasked the presence of voltage-activated (2120 mV), transient currents observed in the presence of K-aspartate (KAsp), but not CsCl (Fig. 3B ). CON HNPs showed higher currents (larger amplitude), and faster inactivation than DS HNPs. The current-to-voltage relationship of these transient currents could be further observed in Figure 3C , where the voltage-dependent currents were clearly observed only in the presence of internal K+. Since voltage-gated outward potassium channels KCNA3 and KCNA5 have been reported to be associated with oligoprogenitor differentiation and proliferation changes, we further tested the expression of these proteins in 18 W CON and DS frontal cortices by western blot. We found an appreciable reduction in the KCNA3 expression in DS samples, but did not detect the expression of KCNA5 (Fig. 3D ). These data strongly indicate the presence of voltage-dependent K+ currents, diminished expression levels of the KNCA3 channel in DS as opposed to CON HNPs and a corresponding decrease in K+ currents upon activation.
OLIG2 regulates voltage-gated potassium channel expression
Although both OLIG1 and OLIG2 transcription factors have been reported to influence proliferation and oligodendrocyte differentiation, the temporal pattern of OLIG2 expression in DS progenitors suggested that it might play a more dominant role in DS HNPs maldevelopment in the current study. We therefore asked if over-expression of OLIG2 could change KCNA3 expression and proliferation within CON HNPs concurrently, and if blocking OLIG2 over-expression in DS HNPs could reverse these phenotypes. First, we infected CON HNPs with lentivirus carrying either OLIG2 or ZsGreen reporter gene at different viral dosages. Cells were harvested for western blot analyses 3 days post-infection. OLIG2 overexpression dose-dependently inhibited PCNA and KCNA3 expression ( Fig. 4A ). The dosing of the virus affects the level or expression of the target genes. PAX6 expression was also inhibited by OLIG2 over-expression (Supplementary Material, Fig. S4 ), suggesting a decrease in the neuronal progenitor pool. Consistent with the results in human DS progenitor cells, similar phenotypes were also observed with decreased proliferation and KCNA3 expression in frontal cortices of E14.5 Olig2 transgenic mice (Fig. 4B ). Additionally, infecting DS HNPs with OLIG2 shRNA reversed the change in PCNA and KCNA3 expression shown by western blot (Fig. 4C ) and immunostaining in DS neurospheres that constitutively over-express Olig2 (Fig. 4D ). The knockdown of OLIG2 expression in OLIG2 shRNA-infected DS cells (fluorescein) results in a decline in rhodamine fluorescence ( Fig. 4D , upper channel). The decline in OLIG2 expression also appears to be associated with a compensatory upregulation in OLIG1 levels ( Fig. 4D , middle channel). Increased KCNA3 levels were also reflected by the intensity of rhodamine staining within OLIG2 shRNA-infected cells (fluoroscein labeled, Fig. 4D , lower channel). In total, these studies suggest that OLIG2 over-expression inhibits proliferation and KCNA3 expression, whereas OLIG2 inhibition promotes proliferation and KCNA3 expression within human and mouse neural progenitors from the forebrain. 
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Voltage-gated potassium channel activity regulates HNPs proliferation
Voltage-gated potassium channels have been suggested to control proliferation in oligoprogenitor cells (19) . Most voltage-gated potassium channels are sensitive to K+ channel blocker, tetraethylammonium (TEA), whereas KCNA3 has a more specific blocker ShK (23) . Additionally, glutamate at low doses (1 mM) has been used to activate KCNA3 channels (24) . To confirm if voltage-gated potassium channels especially KCNA3 could regulate the proliferation of HNPs, we treated CON 18 W GA HNPs with the above inhibitors/activators, and examined the HNPs proliferation rates by BrdU and Ki67 immunostaining after 24 h. Both TEA and ShK exposure inhibited the proliferation of HNPs, although more generalized inhibition of potassium channel activity through TEA showed higher potency than ShK, suggesting the involvement of other potassium channels besides KCNA3 ( Fig. 5A, Supplementary Material,  Fig. S5A ). To test which population of HNPs is affected by potassium channel block, we did double staining of BrdU with neural stem cell marker NESTIN, neuronal marker MAP2 and oligoprogenitor marker O4, in control neuroprogenitor cells treated with ShK 1 day after plating. The proliferating cells in each stained population are reduced after ShK treatment. These results suggest that ShK affects all proliferating neuroprogenitor cells, although the majority population of HNPs is neural stem cells (NESTIN+, 50%) (Supplementary Material, Fig. S5B ). Varying concentrations of ShK lead to a decline in HNPs proliferation in a dose-dependent fashion (Fig. 5B) , and similar results were also appreciated in mouse neuroprogenitor cells (Fig. 5C ). With 1 mM glutamate treatment for 24 h, DS HNPs displayed significantly increased proliferative rates of 50% when assessed by either BrdU incorporation or Ki67 staining, respectively. This effect could be abrogated by preceding inhibition of potassium channels with ShK treatment, indicating that the effects of glutamate activation involved potassium channel activation (Fig. 5D ).
In summary, these data support a model whereby impaired activation of voltage-gated potassium channels including KCNA3 decrease the proliferative rate of DS HNPs, whereas low dose glutamate-dependent activation of KCNA3 could rescue this phenotype.
DISCUSSION
DS is a contiguous gene disorder characterized in part by a reduction in brain size. Over-expression of and interactions between a subset of HSA21 genes produce the DS phenotype.
Here, we show that OLIG2 is over-expressed in DS HNPs at a fairly early stage in neurogenesis and promotes oligodendroglial phenotypes within the progenitor pool. OLIG2 expression levels dose-dependently regulate KCNA3 potassium channel expression and diminished KCNA3 activation leads to a reduction in HNPs proliferation. These findings establish a potential mechanistic link between OLIG2 and the reduced brain size seen in DS. Some discrepancy exists as to the underlying cause of the reduction in DS brain size. Early studies using different aged DS fetal brain suggested that the prenatal retardation of neurogenesis and loss in neuronal numbers began after 22 W GA (25) . This conclusion was based on the observation that no reduction in neuronal numbers was observed in the early stages of cortical development. However, subsequent studies using trisomy 16 mouse models, including the Ts65Dn and Ts1Cje mice, described elongated cell cycles in cortical progenitors, impaired division in hippocampal progenitors resulting in reduced numbers of granule neurons and elongation of the cell cycle in cerebellar granule cell precursors (6) . In addition, dowregulation of several cell cycle progression genes such as Mcm7, Bcra2, Prim1, Cenpo and Aurka in trisomic neurospheres, and reduced proliferation were found in neural progenitor cells but not neural stem cells of the trisomy mice (26) . While these observations might suggest differences between DS in human and mice, more recent work showed a reduction in proliferation in both hippocampus and neocortical germinal matrix of 17-21 W GA fetal DS brains (2, 5) . The current studies demonstrate a similar finding of reduced proliferation at even earlier GAs from 14 to 18 W, within both tissue of DS VZ and viable HNP cultures. Taken in total, the earlier changes in the progenitor pool might not reflect changes in the neuronal population until later in gestation, and both impairments in proliferation as well as neuronal differentiation likely contribute to the reduction in brain size.
DS progenitors adopt glial and oligodendroglial characteristics, thereby promoting a phenotypic shift in the progenitor pool. Previously, we have shown that DS HNPs between 14 and 21 W GA exhibited increased expression of glia markers such as GFAP in the DS frontal cortex due to reciprocal upregulation of HSA21-localized S100B and APP (4). In the current study, HSA21-localized OLIG2 appears to promote expression of oligodendroglial markers (OLIG2, PDGFRA) with a corresponding decrement in neuronogenesis (DCX, MAP2). In addition to changes in proliferation rates, these finding would suggest that impaired neurogenesis in DS may also result from a progressive decline in the neuronal progenitor pool. A second effect of this phenotypic shift might lead to changes in CNS myelination and more specifically, an increase in myelin-associated proteins. However, myelin formation in DS actually slows in the brain when compared with genetically normal children some 2 months after birth (27) . While our observation of increased oligoprogenitor cells in 14-21 W GA cortex would seemingly contradict these later stage observations, the progressive decline in the progenitor pool with time will produce less oligodendrocytes than normal control, which could overcome the increased oligodendrogenesis we observed in the early stage of cortical development. Additionally, it is unclear how the later stages of oligodendrocyte maturation and myelination are affected by this phenotypic shift. For example, prior work has shown upregulation of OLIG2+ oligoprogenitors in response to trauma, with these cells differentiating into reactive-type astrocytes rather than myelinating oligodendrocytes (28) . Finally, accumulation of beta amyloid from APP overexpression and other inflammatory factors might promote myelinated oligodendrocyte cell death, given that the larger cell masses and multiple processes make such cells more vulnerable to cytotoxic injury (29) . A shift toward oligodendroglial progenitor phenotypes promotes a reduction in whole-cell outward K+ currents, leading to the reduced proliferation in DS HNPs. This change may partially explain the reduced proliferation in DS HNPs. Different potassium channel subunits play different roles in cell proliferation and differentiation. For example, Kv7.2/7.3 (KCNQ2/3) direct neuronal differentiation (22), Kv4.2 (KCND2) and Kv1.6 (KCNA6) regulate HNPs proliferation (30) and the Kv1 family controls oligoprogenitor proliferation (31, 32) . Oligoprogenitor cells (OLIG1/2+, PDGFRA+, NG2+) express delayed rectifier Shaker family K+ channels Kv1.1-Kv1.6 (KCNA1 -KCNA6) and Kv3.1 (KCNC1), which have been suggested to have a key role in oligoprogenitors cell cycle progression (19, (31) (32) (33) (34) (35) . Consistent with these observations, we observed reduced K+ channel activity in the setting of diminished expression levels of KCNA3 in DS HNPs. The expression of other Kv1 family channels (KCNA1, 2, 4, 5 and 6) were not detected in our HNPs and therefore, likely did not contribute to the DS electrophysiological phenotype. While it is not clear how K+ channels regulate proliferation, some reports have found that K+ channel blockade increases CDK inhibitors and therefore impairs proliferation (19, 36) . Other studies suggest that blocking K+ channels increases cell volume and thereby decreases the rate of cell proliferation (37) . The current work now provides a potential explanation for the prolongation of the cell cycle seen in the trisomy 16 mouse models. A decline in the outward voltage-gated K+ channel expression and activity in DS progenitors would be expected to lead to a prolonged cell cycle and diminished proliferation rates. It remains to be established whether all precursors or only oligodendroglial precursors exhibit defective potassium currents.
The function of OLIG2 in neural progenitors is not entirely known. Prior work has shown that Olig2 over-expression by retroviral injection into lateral ventricles of P2 rats directs astrocyte and oligodendrocyte formation in postnatal SVZ cells (38) . We find a similar shift in DS HNPs that constitutively over-express OLIG2. We now also observe that OLIG2 over-expression (in Olig2 transgenic mice, OLIG2 viral infection or OLIG2-overexpressing DS HNPs) show reduced KCNA3 expression and consequent proliferation rates. More recent studies, however, have reported that phosphorylated Olig2 targeted p53, inhibited p53-and p21-induced proliferation arrests and resulted in an increase of proliferation rate in human glioma neural progenitor cells (39) . It remains to be seen whether or how potassium channel activity might regulate Olig2 phosphorylation states. In another study, Olig1 and Olig2 triplication have also been shown to increase inhibitory interneuron production in medial ganglionic eminences of the Ts65Dn mouse ventral telencephalon (40) . These seemingly conflicting results might be due to the differences in cell locations, developmental stages as well as differences in Olig1/2 interacting molecules or epigenetic modifications, which can change dynamically during cortical development.
In conclusion, in the current study, we describe an increase in oligodendroglial traits in human DS neural progenitors. This phenotypic shift correlates with abnormal K+ channel currents, which can be linked to an observed decrease in progenitor proliferation. These findings provide a partial but novel explanation for the reduction in brain size seen in DS individuals.
MATERIALS AND METHODS
Human tissue, ethical and licensing considerations
The study has been approved by the Institutional Review Board (IRB) at the Beth Israel Deaconess Medical Center Summary of whole-cell current experiments of HNP cells. Whole-cell currents are obtained in the presence of either K-Aspartate (KAsp) or CsCl-TEA (CsCl) in the pipette (intracellular) and NaCl bathing solution. Reversal potentials are obtained by linear fitting of negative potentials from whole-cell currents obtained between +100 mV, from a holding potential of either 0 or 2120 mV.
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Human Molecular Genetics, 2012, Vol. 21, No. 10 and Brigham and Women's Hospital. The identified human discarded tissues were obtained from pathological samples obtained during planned, induced abortions with post-mortem intervals under 4 h. The tissue sections or neural progenitors from DS and age-matched control brains (GA 14 W and 18 W) were used in this study for each of the experiments described. It is a discarded tissue protocol and is exempt from informed consent, as determined by the ethics and IRB review committee at BIDMC, and no informed consent was obtained. The approved protocol number is 2004-P-000299/ 5. The detail information of the tissues is listed in Table 3 .
Antibodies and reagents
See in Supplementary Methods.
HNPs cell cultures
Methods for VZ dissection and dissociation follow general guidelines described previously (3) . For detail, see Supplementary Methods.
Transgenic mice
Archival brain tissue from E14.5 transgenic mice, Ts-Nestin-Olig2 (Olig2 over-expression), was provided by Professor Q. Richard Lu. The whole brains were solubilized in lysis buffer for western blot analyses. The animal studies have been approved by the Institutional Animal Care & Use Committee (IACUC) at the Beth Israel Deaconess Medical Center. The approved IACUC protocol number for animal work is 003-2011/100789.
Constructs, viral production and infection
pHAGE-CMV-MCS-IZsGreenW-OLIG2 and pLKO.1puro-GFP-hOLIG2'D3'shRNA constructs were gifts of Professor Charles Stiles. Production of lentiviruses was done in 293T cells as described by Richard Mulligan's lab (41) . The multiplicity of infection of viruses were 1. Dissociated neural progenitor cells were infected with lentivirus carrying the target genes, and kept in neural stem cell medium for 3 days before analysis.
Immunostaining
Fetal cortices were fixed in 4% PFA for 3 days, and then placed in 20% sucrose for 1 day before freezing at 2808C. The blocks were cut into 14 mm thick sections. Tissue sections after antigen retrieval or fixed cells were placed in blocking solution with phosphate buffered saline (PBS) containing 3% goat serum, incubated overnight in the appropriate antibody and processed through standard fluorescent secondaries (CY2, CY3, Jackson Immunoresearch Laboratories, Westgrove, PA, USA, and FITC, Sigma). Specimens were examined using confocal fluorescence microscopy after mounting in appropriate media. Cells staining positive for expressed 
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Human Molecular Genetics, 2012, Vol. 21, No. 10 markers were counted against the total cells in five randomly chosen microscopic fields (0.02 mm 2 ; magnification: ×630) with 5 -10 independent samples used for each experimental variable. Cells were mounted on slides and scanned by fluorescence microscope. The intensity of KCNA3 staining was measured in 10 randomly chosen GFP-expressed cells from nine independent samples.
Western blot
Proteins were extracted from neurospheres or cell lines according to the previously described methods (3) . Briefly, cells were solubilized in lysis buffer, separated on a 7.5% sodium dodecyl sulfate -polyacrylamide gel electrophoresis gel and transferred onto polyvinylidene fluoride membrane. The membrane was probed with the appropriate antibody and detected by enhanced chemiluminescence. The exposed blots were then analyzed with image J using integrated density (the product of Area and Mean Gray Value) as the measurement for immuno-stained bands.
Electrophysiology
Clusters of precursor are not amenable to patch clamping and were prepared as described below. Briefly, to obtain single cells, clusters were centrifuged (3 min, 1500 rpm, 208C, Allegra X-15R, Beckman Coulter centrifuge) in original NPBM medium (Neural Progenitor Basal Medium, Cambrex BioScience). The pellet was replaced and washed with calcium-free PBS (GIBCO), followed by a second centrifugation at the same speed and time and resuspended in 1 ml of a trypsin-ethylenediaminetetraacetic acid solution (0.25%, Sigma). Clusters were visually disaggregated for 5 min after shaking with a vortex. Cell suspension was supplemented with the medium, and plated in a six-well tray, containing sterile 5 mm round cover slips used for patch clamping. Cells were used for experimentation between 24 and 48 h after enzymatic treatment. Only cells that had not changed in shape, and did not spread much during this time were used for experimentation ( Fig. 3A ). Cells were prepared as above and viewed using an Olympus IMT2 inverted microscope. The patch pipettes (KG-33, Garner Glass Company)
were filled with a solution containing in mM: K-Aspartate 115, NaCl 15, MgSO 4 0.8, ethylene glycol tetraacetic acid (EGTA) 1.0 and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 20, adjusted to pH 7.4 with N-methyl-D-glucamine. Another intracellular solution, containing in mM: CsCl 125, TEA-Cl 20, EGTA 5, HEPES 20, pH 7.4, was also used to determine whole-cell currents while blocking endogenous K+ currents. The cell bathing solution contained in mM: NaCl 135, KCl 5.0, MgCl 2 0.8, CaCl 2 1.2, HEPES 20, adjusted to pH 7.4 with N-methyl-D-glucamine. Cells were patched at room temperature. Three different voltage protocols were used to determine the whole-cell conductance of HNPs. Experiments were conducted with a Dagan 3900 patch clamp amplifier (Dagan Corp.), low-pass filtered at 10 kHz, digitized and analyzed with pClamp10.0 software (Axon Instruments, Union City, CA, USA). All experiments were conducted at room temperature.
Statistical analyses
Results were expressed as the mean + SD of n experiments. Statistical analysis was performed with Student's t-test or one-way ANOVA, with P , 0.05 considered significant.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online. 
